Detection of residual disease in acute leukemia using immunological markers.
Ryan
D H
DH
van Dongen
J J
JJ
D000208:Acute Disease; D000782:Aneuploidy; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000943:Antigens, Differentiation / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001853:Bone Marrow / Q000032:analysis / Q000473:pathology; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D004273:DNA, Neoplasm / Q000032:analysis; D004351:Drug Resistance; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D007942:Leukemia, Experimental / Q000473:pathology; D009363:Neoplasm Proteins / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D012074:Remission Induction; D014410:Tumor Stem Cell Assay
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm